Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Neurologia I Neurochirurgia Polska|October 19, 2007
[Dopamine agonists--pharmacological similarities and differences]Krystyna Honczarenko, Monika Białecka
Current Genomics|February 18, 2014
Pharmacogenetics of Parkinson's disease - through mechanisms of drug actionsMarek Droździk, Monika Białecka, Mateusz Kurzawski
International Journal of Molecular Sciences|November 27, 2021
A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson's DiseaseAnna Pierzchlińska, Marek Droździk, Monika Białecka
Neurodegenerative Disease Management|February 26, 2015
Pharmacogenetic considerations in the treatment of Parkinson's diseaseMateusz Kurzawski, Monika Białecka, Marek Droździk
Annales Academiae Medicae Stetinensis|February 11, 2010
[Molecular and neuronal mechanisms of drug addiction]Anna Machoy-Mokrzyńska, Krzysztof Borowiak, Monika Białecka
Neurologia I Neurochirurgia Polska|January 8, 2010
[Optimisation of treatment of Parkinson's disease with levodopa]Monika Białecka, Urszula Adamiak, Barbara Gawrońska-Szklarz
Neurologia I Neurochirurgia Polska|February 8, 2022
Cannabis and cannabinoids: pharmacology and therapeutic potentialMałgorzata Śmiarowska, Monika Białecka, Anna Machoy-Mokrzyńska
Przeglad Lekarski|May 8, 2007
[Evaluation of individual vulnerability to HIV infection of health care employees--hope or reality?]Piotr Białecki, Mateusz Kurzawski, Maria Gańczak, et al.
Neurologia I Neurochirurgia Polska|May 20, 2018
The impact of Apolipoprotein E alleles on cognitive performance in patients with Parkinson's diseaseAnna Pierzchlińska, Monika Białecka, Mateusz Kurzawski, et al.
Pageof 6